117 related articles for article (PubMed ID: 3259908)
1. In vitro testing of the antibacterial activity of fosfomycin trometamol against urinary pathogens.
Rossi L; Fontana R; Meloni GA
Chemioterapia; 1988 Feb; 7(1):10-4. PubMed ID: 3259908
[TBL] [Abstract][Full Text] [Related]
2. Microbiological basis for the use of fosfomycin trometamol as single-dose therapy for simple cystitis.
Gismondo MR; Romeo MA; Lo Bue AM; Chisari G; Nicoletti G
Chemioterapia; 1986 Aug; 5(4):278-82. PubMed ID: 3094965
[TBL] [Abstract][Full Text] [Related]
3. Influence of pH, inoculum and media on the in vitro bactericidal activity of fosfomycin trometamol, norfloxacin and cotrimoxazole.
Albini E; Belluco G; Marca G
Chemioterapia; 1986 Aug; 5(4):268-72. PubMed ID: 3533286
[TBL] [Abstract][Full Text] [Related]
4. Antibacterial activity in human urine of fosfomycin trometamol in an in vitro model of the urinary bladder.
Dubini F; Riviera L
Chemioterapia; 1988 Feb; 7(1):15-9. PubMed ID: 3259909
[TBL] [Abstract][Full Text] [Related]
5. Treatment of experimental cystitis in the rat with a single dose of fosfomycin trometamol.
Dubini F; Riviera L
Chemioterapia; 1988 Feb; 7(1):24-8. PubMed ID: 3259910
[TBL] [Abstract][Full Text] [Related]
6. Effect of fosfomycin trometamol on bacterial adhesion in comparison with other chemotherapeutic agents.
Carlone NA; Borsotto M; Cuffini AM; Savoia D
Eur Urol; 1987; 13 Suppl 1():86-91. PubMed ID: 3552703
[TBL] [Abstract][Full Text] [Related]
7. Urinary pathogens and bacterial sensitivity in hospitalized urological patients based upon clinical aspects.
Naber KG; Bauernfeind A; Dietlein G; Wittenberger R
Scand J Urol Nephrol Suppl; 1987; 104():47-57. PubMed ID: 3501901
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of fosfomycin against ciprofloxacin-resistant or extended-spectrum beta-lactamase-producing Escherichia coli isolated from urine and blood.
Ko KS; Suh JY; Peck KR; Lee MY; Oh WS; Kwon KT; Jung DS; Lee NY; Song JH
Diagn Microbiol Infect Dis; 2007 May; 58(1):111-5. PubMed ID: 17300900
[TBL] [Abstract][Full Text] [Related]
9. Fosfomycin tromethamine as second agent for the treatment of acute, uncomplicated urinary tract infections in adult female patients in The Netherlands?
Knottnerus BJ; Nys S; Ter Riet G; Donker G; Geerlings SE; Stobberingh E
J Antimicrob Chemother; 2008 Aug; 62(2):356-9. PubMed ID: 18424789
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of the combination trimethoprim plus sulfamethoxazole compared with that of other chemotherapeutic agents.
Focht J; Klietmann W; Nösner K
Arzneimittelforschung; 1988 Aug; 38(8):1085-8. PubMed ID: 3264166
[TBL] [Abstract][Full Text] [Related]
11. In vitro susceptibility testing procedures for fosfomycin tromethamine.
Barry AL; Fuchs PC
Antimicrob Agents Chemother; 1991 Jun; 35(6):1235-8. PubMed ID: 1929270
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of fosfomycin trometamol against pathogens from urinary tract infections: a Spanish multicenter study.
García-Rodríguez JA; Trujillano Martín I; Baquero F; Cisterna R; Gobernado M; Liñares F; Martín-Luengo F; Piédrola G
J Chemother; 1997 Dec; 9(6):394-402. PubMed ID: 9491838
[TBL] [Abstract][Full Text] [Related]
13. Resistance of urinary tract isolates of Escherichia coli to trimethoprim, cotrimoxazole and ampicillin.
Bailey RR; Peddie BA
N Z Med J; 1988 Apr; 101(844):216-7. PubMed ID: 3283613
[No Abstract] [Full Text] [Related]
14. [Comparative activity of norfloxacin and other chemotherapeutic agents on the adhesion of bacteria of the uro-vaginal tract to uroepithelial cells].
Carlone NA; Borsotto M; Cuffini AM; Savoia D
G Batteriol Virol Immunol; 1985; 78(7-12):185-204. PubMed ID: 3879893
[TBL] [Abstract][Full Text] [Related]
15. [Evolution from 1976 to 1986 of bacterial prevalence and sensitivity to urinary antibiotics of bacteria isolated from urine cultures at a city microbiology laboratory].
Chouteau J
Pathol Biol (Paris); 1988 May; 36(5):439-41. PubMed ID: 3136425
[TBL] [Abstract][Full Text] [Related]
16. Norfloxacin versus co-trimoxazole in the treatment of recurring urinary tract infections in men.
Sabbaj J; Hoagland VL; Cook T
Scand J Infect Dis Suppl; 1986; 48():48-53. PubMed ID: 3490684
[TBL] [Abstract][Full Text] [Related]
17. Fosfomycin distribution in the lower urinary tract after administration of fosfomycin trometamol salt.
Scaglione F; Cicchetti F; Demartini G; Arcidiacono M
Int J Clin Pharmacol Res; 1994; 14(3):107-9. PubMed ID: 7883387
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility of recent bacterial isolates to cefdinir and selected antibiotics among children with urinary tract infections.
Bonsu BK; Shuler L; Sawicki L; Dorst P; Cohen DM
Acad Emerg Med; 2006 Jan; 13(1):76-81. PubMed ID: 16365328
[TBL] [Abstract][Full Text] [Related]
19. [Comparative activity of sulfamethoxazole-trimethoprim (SMZ-TMP) on bacteria responsible for ORL infections].
Joly B; Sirot D; Cluzel M; Chanal M; Bruneau D
Pathol Biol (Paris); 1984 Jun; 32(6):689-92. PubMed ID: 6611536
[TBL] [Abstract][Full Text] [Related]
20. [Antibacterial activity of co-trimoxazole and tetroxoprim/sulfadiazine in vitro (author's transl)].
Hahn H; Kirov A
Arzneimittelforschung; 1980; 30(7):1047-8. PubMed ID: 7191284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
